How to buy Precipio shares

Own Precipio shares in just a few minutes.

Picture not described

We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!

Precipio, Inc (PRPO) is a leading diagnostics & research business with stocks listed in the US. It opened the day at US$3.99 after a previous close of US$3.99. During the day the price has varied from a low of USD3.7616 to a high of USD4.65. The latest price was USD3.77 (25 minute delay). Precipio is listed on the NASDAQ. All prices are listed in US Dollars.

How to buy shares in Precipio

  1. Compare share trading platforms. To buy shares in a US company from Australia you'll need to find a trading platform that offers access to US stock markets. If you're just starting out, look for a platform with low brokerage and foreign exchange fees.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Precipio. Find the share by name or ticker symbol: PRPO. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Precipio reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of US$3.44, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs. You may be able to buy a fractional share of Precipio, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Precipio. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Precipio share price

Use our graph to track the performance of PRPO stocks over time.

Precipio shares at a glance

Information last updated 2021-06-15.
OpenUS$3.99
HighUS$4.65
LowUS$3.7616
CloseUS$3.77
Previous closeUS$3.99
Change US$-0.22
Change % -5.5138%
Volume 10,633,746
Information last updated 2021-06-10.
52-week rangeUS$0.92 - US$5.75
50-day moving average US$3.5189
200-day moving average US$2.7307
Target priceUS$6.65
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) US$-5.807

Compare share trading platforms to buy stock

Name Product Standard brokerage for US shares Inactivity fee Currency conversion fee Markets
eToro (US, EU stock trading)
US$0
US$10 per month if there’s been no login for 12 months
0.50%
US shares, ETFs
Zero brokerage share trading on US stocks with trades as low as $50.
Join the world’s biggest social trading network when you trade stocks, commodities and currencies from the one account.
IG Share Trading
Finder Award
IG Share Trading
US$0
$50 per quarter if you make fewer than three trades in that period
0.70%
ASX shares, Global shares
$0 brokerage for US and global shares plus get an active trader discount of $5 commission on Australian shares.
Enjoy some of the lowest brokerage fees on the market when trading Australian shares, international shares, plus get access to 24-hour customer support.
Saxo Capital Markets (Classic account)
US$9.9
No
0.75%
ASX shares, Global shares, Forex, CFDs, Margin trading, Options trading, ETFs
Acess 19,000+ stocks on 37 exchanges worldwide
Low fees for Australian and global share trading, no inactivity fees, low currency conversion fee and optimised for mobile.
CMC Markets Stockbroking
US$0
No
0.60%
ASX shares, Global shares, mFunds, ETFs
$0 brokerage on global shares including US, UK and Japan markets.
Trade up to 9,000 products, including shares, ETFs and managed funds, plus access up to 15 major global and Australian stock exchanges.
loading

Compare up to 4 providers

The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.

Is it a good time to buy Precipio stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Precipio price performance over time

Historical closes compared with the last close of $3.77

1 week (2021-06-09) -0.79%
1 month (2021-05-14) -5.75%
3 months (2021-03-16) 51.41%
6 months (2020-12-16) 72.94%
1 year (2020-06-16) 249.07%
2 years (2019-06-14) -7.60%
3 years (2018-06-15) -48.39%
5 years (2016-06-16) -58.10%

Precipio financials

Revenue TTM US$6.7 million
Gross profit TTM US$1.2 million
Return on assets TTM -28.79%
Return on equity TTM -68.44%
Profit margin -132.42%
Book value 0.801
Market capitalisation US$84.7 million

TTM: trailing 12 months

Shorting Precipio shares

There are currently 1.9 million Precipio shares held short by investors – that's known as Precipio's "short interest". This figure is 132.7% up from 830,056 last month.

There are a few different ways that this level of interest in shorting Precipio shares can be evaluated.

Precipio's "short interest ratio" (SIR)

Precipio's "short interest ratio" (SIR) is the quantity of Precipio shares currently shorted divided by the average quantity of Precipio shares traded daily (recently around 48.3 million). Precipio's SIR currently stands at 0.04. In other words for every 100,000 Precipio shares traded daily on the market, roughly 40 shares are currently held short.

However Precipio's short interest can also be evaluated against the total number of Precipio shares, or, against the total number of tradable Precipio shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Precipio's short interest could be expressed as 0.06% of the outstanding shares (for every 100,000 Precipio shares in existence, roughly 60 shares are currently held short) or 0.0612% of the tradable shares (for every 100,000 tradable Precipio shares, roughly 61 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Precipio.

Find out more about how you can short Precipio stock.

Precipio share dividends

We're not expecting Precipio to pay a dividend over the next 12 months.

Have Precipio's shares ever split?

Precipio's shares were split on a 1:15 basis on 28 April 2019. So if you had owned 15 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Precipio shares – just the quantity. However, indirectly, the new 1400% higher share price could have impacted the market appetite for Precipio shares which in turn could have impacted Precipio's share price.

Precipio share price volatility

Over the last 12 months, Precipio's shares have ranged in value from as little as US$0.92 up to US$5.75. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Precipio's is 2.644. This would suggest that Precipio's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Precipio overview

Precipio, Inc., a cancer diagnostics and reagent technology company, provides diagnostic products and services in the United States oncology market. Its product consists of clinical diagnostic services. The company's clinical diagnostic services focus on the diagnosis of different hematopoietic or blood-related cancers to oncologists. Its cytogenetics media IV-Cell enables laboratories to arrive at more accurate results; HemeScreen panel enables hospitals and laboratories to run an important genetic mutation test; and ICE-COLD-PCR enables detection of abnormalities in blood samples. The company also operates a cancer diagnostic laboratory located in New Haven, Connecticut. It sells ICE-COLD-PCR technology kits to bio-pharma customers, clinical research, HemeScreen, and COVID-19 antibody tests. The company serves oncologists, hospitals, reference laboratories, physician-office labs, and pharma and biotech companies. Precipio, Inc. has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment, such as the Yale School of Medicine, Harvard's Dana-Farber Cancer Institute, and the University of Pennsylvania. The company is based in New Haven, Connecticut.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com.au:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com.au is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder only provides general advice and factual information, so consider your own circumstances, or seek advice before you decide to act on our content. By submitting a question, you're accepting our Terms of Use, Disclaimer & Privacy Policy and Privacy & Cookies Policy.
Go to site
Not sure what platform to go with?
Take this quick quiz to find the right share trading platform